Streetbeat News

Price Targets

XPEL

EF Hutton analyst Tim Moore has reiterated a 'Buy' rating on XPEL (NASDAQ:XPEL) and maintained a price target of $104.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 8:06 am

NVDA

Analysts at TD Cowen have revised their price target for Nvidia Corporation (NASDAQ:NVDA) to $700 from the previously projected $600, suggesting a potential 50% stock gain. The analysts maintain an Outperform rating on Nvidia, citing the company's superior technology, innovation, and growth-oriented investments as reasons for the optimistic outlook.

Portfolio Pulse from Benzinga Neuro

October 12, 2023 | 8:06 am

REGN

In the last quarter, Regeneron Pharmaceuticals (NASDAQ:REGN) received 17 analyst ratings, with the majority being bullish or somewhat bullish. The company's average 12-month price target is $922.88, which has increased by 6.6% over the past month.

Portfolio Pulse from Benzinga Insights

October 11, 2023 | 9:00 pm

BABA

A significant number of investors have taken a bearish stance on Alibaba Group Holding (NYSE:BABA), with 60% of detected trades showing bearish expectations. The targeted price range for Alibaba over the last 3 months is from $65.0 to $265.0. The current price of BABA is up 0.75% at $87.82. Benchmark has downgraded its action to Buy with a price target of $180.

Portfolio Pulse from Benzinga Insights

October 11, 2023 | 8:16 pm

AHCO

Truist Securities analyst David Macdonald has maintained a 'Buy' rating on AdaptHealth (NASDAQ:AHCO), but lowered the price target from $18 to $14.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2023 | 8:02 pm

CYH

Truist Securities analyst David Macdonald has maintained a 'Hold' rating on Community Health Sys (NYSE:CYH) and lowered the price target from $5 to $3.5.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2023 | 8:00 pm

DVA

Truist Securities analyst David Macdonald maintains a Hold rating on DaVita (NYSE:DVA) and lowers the price target from $115 to $104.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2023 | 7:58 pm

FRO

Jefferies analyst Omar Nokta maintains a Hold rating on Frontline (NYSE:FRO) and raises the price target from $17 to $19.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2023 | 7:56 pm

FMS

Truist Securities analyst David Macdonald maintains a 'Hold' rating on Fresenius Medical Care (NYSE:FMS) and lowers the price target from $28 to $24.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2023 | 7:55 pm

MD

Truist Securities analyst David Macdonald maintains a 'Hold' rating on Pediatrix Medical Group (NYSE:MD) and lowers the price target from $16 to $15.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2023 | 7:53 pm